Virtus ETF Advisers LLC Viking Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

$234 Million
Q4 2024

A detailed history of Virtus ETF Advisers LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 1,485 shares of VKTX stock, worth $43,837. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,485

Previous 1,771 16.15%

Holding current value

$43,837

Previous $112,000 47.32%

% of portfolio

0.03%

Previous 0.05%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$38.28 - $78.03 $10,948 - $22,316	-286 Reduced 16.15%	1,485 $59,000
Q3 2024 Nov 14, 2024	BUY	$49.84 - $70.47 $1,644 - $2,325	33 Added 1.9%	1,771 $112,000
Q2 2024 Aug 14, 2024	SELL	$47.39 - $80.2 $131,412 - $222,394	-2,773 Reduced 61.47%	1,738 $92,000
Q1 2024 May 15, 2024	SELL	$17.4 - $94.5 $5,324 - $28,917	-306 Reduced 6.35%	4,511 $369,000
Q4 2023 Feb 15, 2024	BUY	$9.24 - $19.64 $3,686 - $7,836	399 Added 9.03%	4,817 $89,000
Q3 2023 Nov 07, 2023	SELL	$10.92 - $16.0 $4,793 - $7,024	-439 Reduced 9.04%	4,418 $48,000
Q2 2023 Aug 14, 2023	BUY	$14.84 - $24.79 $72,077 - $120,405	4,857 New	4,857 $78,000
Q2 2022 Aug 12, 2022	SELL	$2.11 - $3.15 $69,013 - $103,030	-32,708 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.0 - $4.88 $5,835 - $9,491	-1,945 Reduced 5.61%	32,708 $98,000
Q4 2021 Feb 14, 2022	SELL	$4.6 - $6.72 $1,462 - $2,136	-318 Reduced 0.91%	34,653 $159,000
Q3 2021 Nov 15, 2021	SELL	$5.58 - $7.04 $10,155 - $12,812	-1,820 Reduced 4.95%	34,971 $220,000
Q2 2021 Aug 10, 2021	SELL	$5.19 - $6.73 $41,333 - $53,597	-7,964 Reduced 17.79%	36,791 $220,000
Q1 2021 May 17, 2021	BUY	$5.74 - $9.67 $4,528 - $7,629	789 Added 1.79%	44,755 $283,000
Q4 2020 Feb 12, 2021	BUY	$5.3 - $6.71 $7,732 - $9,789	1,459 Added 3.43%	43,966 $248,000
Q3 2020 Nov 13, 2020	SELL	$5.73 - $8.11 $33,308 - $47,143	-5,813 Reduced 12.03%	42,507 $247,000
Q2 2020 Aug 05, 2020	BUY	$4.35 - $8.08 $13,484 - $25,048	3,100 Added 6.86%	48,320 $348,000
Q1 2020 May 14, 2020	SELL	$3.45 - $7.95 $22,780 - $52,493	-6,603 Reduced 12.74%	45,220 $212,000
Q4 2019 Feb 13, 2020	BUY	$6.38 - $8.73 $125,507 - $171,736	19,672 Added 61.19%	51,823 $416,000
Q3 2019 Nov 12, 2019	SELL	$6.55 - $8.6 $11,724 - $15,394	-1,790 Reduced 5.27%	32,151 $221,000
Q2 2019 Aug 13, 2019	BUY	$7.67 - $10.63 $39,017 - $54,074	5,087 Added 17.63%	33,941 $282,000
Q1 2019 May 14, 2019	SELL	$7.58 - $9.94 $26,204 - $34,362	-3,457 Reduced 10.7%	28,854 $287,000
Q4 2018 Feb 05, 2019	SELL	$7.16 - $16.21 $54,766 - $123,990	-7,649 Reduced 19.14%	32,311 $247,000
Q3 2018 Nov 14, 2018	SELL	$9.7 - $19.65 $284,646 - $576,629	-29,345 Reduced 42.34%	39,960 $696,000
Q2 2018 Aug 10, 2018	BUY	$3.88 - $12.74 $268,903 - $882,945	69,305 New	69,305 $658,000

Others Institutions Holding VKTX

# of Institutions

466

Shares Held

65.8M

Call Options Held

5.84M

Put Options Held

3.76M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $2.26B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Viking Therapeutics, Inc. Transaction History